This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Mridula Dogra, PhD
Director at Eli Lilly and Company
Speaker

Profile

Mridula Dogra is a Director at Eli Lilly & Company with more than 11 years of experience advancing pharmaceutical drug development. Her expertise spans formulation and drug delivery, drug metabolism, and pharmacometrics, with specialization in peptide and small molecule therapeutics. As an active contributor to the field, she has made contributions through patents, peer-reviewed publications, and presentations at major scientific conferences. Mridula holds a Ph.D. in Molecular Medicine from the University of Auckland and an M.S. in Pharmacometrics from the University of Maryland. Beyond her scientific achievements, she is equally committed to people — actively mentoring the next generation of researchers and championing well-being in the workplace.

Agenda Sessions

  • Oral Delivery of Peptides

    2:30pm